Vol. 27 (Suppl 2) 2006 Neuro endocrinology letters

On the antioxidant activity of carvedilol in human polymorphonuclear leukocytes in vitro and ex vivo.

OBJECTIVES: In the present study we investigated whether the beta-adrenoceptor antagonist carvedilol (CARV) [Dilatrend] prevented reactive oxygen metabolite (ROM) production in human polymorphonuclear leukocytes (PMNL) or interfered with ROM already generated. To specify the site of action of CARV, we evaluated its effect on extra- and .....